HedgeChatter

  • Home /
  • Tag Archives

BLRX

7:07 am BioLineRx: co announces that professor has received final regulatory approval to evaluate BL-8040 as a treatment for chronic myeloid leukemia

moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioLineRx is hiring next, click here to view […]

April 11, 2014 Bystocknews , Comments Off on 7:07 am BioLineRx: co announces that professor has received final regulatory approval to evaluate BL-8040 as a treatment for chronic myeloid leukemia read more

9:09 am BioLineRx prices public offering of 8.4 mln ADSs, each representing ten of its Ordinary Shares, at $2.50 per ADS for gross proceeds of $21.0 mln

moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioLineRx is hiring next, click here to view […]

March 5, 2014 Bystocknews , Comments Off on 9:09 am BioLineRx prices public offering of 8.4 mln ADSs, each representing ten of its Ordinary Shares, at $2.50 per ADS for gross proceeds of $21.0 mln read more

Nektar Therapeutics (NKTR) Jumps: Stock Up 10.5%

moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioLineRx is hiring next, click here to view […]

March 4, 2014 Bystocknews , Comments Off on Nektar Therapeutics (NKTR) Jumps: Stock Up 10.5% read more

Data on BioLineRx’s BL-8040

moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioLineRx is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on Data on BioLineRx’s BL-8040 read more

7:02 am BioLineRx announces positive preclinical results for novel treatment for chronic myeloid leukemia; BL-8040 study published in Molecular Cancer Therapeutics

moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioLineRx is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on 7:02 am BioLineRx announces positive preclinical results for novel treatment for chronic myeloid leukemia; BL-8040 study published in Molecular Cancer Therapeutics read more

BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia

[PR Newswire] – TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today positive pre-clinical results for BL-8040 in a third indication – as a treatme moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioLineRx is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia read more

BioLineRx Announces Successful Completion of Pre-Clinical Development for BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C

[at noodls] – Jerusalem – October 16, 2012 – BioLineRx (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, announced today that it has successfully completed the pre-clinical development of BL-8020, … moreView todays social media effects on BLRXView the latest stocks trending across Twitter. Click to view dashboard […]

October 16, 2012 Bystocknews , Comments Off on BioLineRx Announces Successful Completion of Pre-Clinical Development for BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C read more